International Publications

1: Duong M, Gülmez SE, Salvo F, Abouelfath A, Lassalle R, Droz C, Blin P, Moore N. Usage patterns of single-ingredient and combined paracetamol in France. Br J Clin Pharmacol. 2016 Apr 5. doi: 10.1111/bcp.12957.

2: Moore N, Salvo F, Duong M, Gülmez SE. Does paracetamol still have a future in osteoarthritis? Lancet 2015, Editorial (accepted for publication).

3: Gülmez SE, Larrey D, Pageaux GP, Bernuau J, Bissoli F, Horsmans Y, Thorburn D, McCormick PA, Stricker B, Toussi M, Lignot-Maleyran S, Micon S, Hamoud F, Lassalle R, Jové J, Blin P, Moore N. Liver transplant associated with paracetamol overdose: results from the 7-country SALT study. Br J Clin Pharm 2015. doi:1 0.1 111/bcp .1263 5

Press Release: “Large but unexplained variations in paracetamol-induced liver failure among European countries: Six-times higher risk in Ireland and a two-fold higher risk in the UK highlighted in study”

4: Gülmez SE. Rational Use of Medicines Implementations in the World. Turkish Clinics J Pharmacol-Special Topics (Special Edition on Rational Use of Medicines) 2015;3(1): 34-44. Invited Review

5: Moore N, Blin P, Gülmez SE. New oral anticoagulants (NOAC) and liver injury. J Hepatol. 2014 Aug;61(2):198-9. doi: 10.1016/j.jhep.2014.05.010. 1 citation.

6: Moore N, Gülmez SE, Blin P, Lassalle R, Jové J, Théophile H, Bégaud B, Larrey D, Bénichou J. Predicting relative risks from case-population data. Epidemiology 2013; 24(6): 935 doi: 10.1097/EDE.0b013e3182a77882 .

7: Gülmez SE, Moore N, Pageaux GP, Lignot S, Horsmans Y, Stricker B, Bernuau J, Bissoli F, Thorburn D, Montastruc JL, Micon S, Hamoud F, Lassalle R, Jové J, Blin P, Larrey D. Causality of drugs involved in acute liver failure leading to transplantation: Results from the Study of Acute Liver Transplant (SALT). Drug Saf 2013; 36:757-764. 2 citations.

8: Gülmez SE. The new pharmacovigilance legislation and impact on observational studies. Marmara Pharmaceutical Journal 2013; 17: 1-4. Invited Review

9: Moore N, Gülmez SE, Blin P. Is paracetamol hepatotoxic at normal doses? BMJ 2013;346:f1519 doi: 10.1136/bmj.f1519 (Publié 12 mars 2013).

10: Gülmez SE, Larrey D, Pageaux GP, Lignot S, Lassalle R, Jové J, Gatta A, McCormick PA, Metselaar HJ, Monteiro E, Thorburn D, Bernal W, Zouboulis-Vafiadis I, de Vries C, Perez-Gutthann S, Sturkenboom M, Bénichou J, Montastruc JL, Horsmans Y, Salvo F, Hamoud F, Micon S, Droz-Perroteau C, Blin P, Moore N. Transplantation for acute liver failure in patients exposed to NSAID or paracetamol: the multinational case-population SALT study. Drug Safety 2013; 36:135-144. 17 citations

11: Gülmez SE, Larrey D, Pageaux GP, Lignot-Maleyran S, deVries C, Sturkenboom M, Perez-Gutthann S, Bénichou J, Bissoli F, Horsmans Y, Bernuau J, Stricker B, Thorburn D, Blin P, Moore N. Methodology for a multinational case-population study on liver toxicity risks with NSAIDs: the Study of Acute Liver Transplant (SALT). Eur J Clin Pharmacol 2013; 69:605-616. 7 citations

12: Moore N, Gülmez SE, Larrey D, Pageaux GP, Lignot-Maleyran S, Lassalle R, Jové J, Pariente A, Blin P, Bénichou J, Bégaud B. Choice of the denominator in case-population studies: Event rates for registration for liver transplantation after exposure to NSAIDs in the SALT study in France. Pharmacoepidemiology and Drug Safety 2013; 22: 160–167. 8 citations

13: Gülmez SE, Lignot-Maleyran S, Devries CS, Sturkenboom M, Micon S, Hamoud F, Blin P, Moore N. Administrative complexities for a European observational study despite directives harmonising requirements. Pharmacoepidemiol Drug Saf 2012 Feb 16; 21(8): 851–56. 5 citations

14: Demircan D, Gülmez SE, Dönertaş B, Topçu I, Yılmaz H, Berkman K, Akıcı A. Use of drugs subject to controlled prescriptions: a retrospective analysis. Balkan Med J 2013; 30: 46-53. 1 citation.

15: Sharma M, Gülmez SE, Lassalle R, Moore N. Use of NSAIDs in France: Analysis from French reimbursement (CNAM-TS) database. Journal of Pharmacy Research 2012; 5(9):4893-96.

16: Gülmez SE. Review: Monoclonal antibodies in hematology. Turkiye Klinikleri J Hem Onc-Special Topics 2012; 5(1):21-4.

17: Gülmez SE, Droz-Perroteau C, Lassalle R, Blin P, Bégaud B, Rossignol M, Moore N, Fourrier-Réglat A. Are traditional NSAIDs prescribed appropriately among French elderly? Results from the CADEUS cohort. Eur J Clin Pharmacol, 2011; 67(8):833-38. 2 citations

18: Gülmez SE, Lassen AT, Aalykke C, Dall M, Andries A, Andersen BS, Hansen JM, Hallas J. Do Statins Protect Against Upper Gastrointestinal Bleeding? Br J Clin Pharmacol 2009; 67(4):460-65. 7 citations.

19: Gülmez SE, Lassen AT, Aalykke C, Dall M, Andries A, Andersen BS, Hansen JM, Hallas J. Spironolactone use and the risk of upper gastrointestinal bleeding: a population-based case-control study. Br J Clin Pharmacol 2008; 66(2):294-9. 11 citations.

20: Gülmez SE, Frederiksen H, Hallas J. Acid suppression not the only culprit of community-acquired pneumonia — Letter-in-Reply. Arch Intern Med 2008; 168:1119.

21: Gülmez SE, Serel S, Uluç A, Can Z, Ergün H. Dipyrone increases the blood flow of arterial dorsal skin flaps. Aesthetic Plast Surg 2008 Sep;32(5):766-70 (Erratum in: Aesthetic Plast Surg. 2008 Sep;32(5):771). 2 citations.

22: Serel S, Gülmez SE, Kaya B, Heper AO, Emiroğlu M. The effect of platelet glycoprotein IIb/IIIa receptor antagonist on survival of rat epigastric island flaps subjected to total venous occlusion. Scand J Plast Reconstr Surg Hand Surg 2008; 42(1):1-6.

23: Gülmez SE, Holm A, Frederiksen H, Jensen TG, Pedersen C, Hallas J. Use of proton pump inhibitors and the risk of community-acquired pneumonia: a population-based case control study. Arch Intern Med 2007; 167:950-5. 168 citations.

24: Gülmez SE, Celik G, Misirligil Z, Tulunay FC. Dipyrone improves small airways functions in asthmatic patients with moderate airway obstruction. J Investig Allergol Clin Immunol 2007;17(4): 242-8. 3 citations.

25: Ergün H, Gülmez SE, Tulunay FC. Cost-minimisation analysis comparing topiramate with standard treatments in migraine prophylaxis. Eur Neurol 2007;58(4):215-7. 3 citations

26: Doğrul A, Gülmez SE, Deveci MS, Gül H, Ossipov MH, Porreca F, Tulunay FC. Local antinociceptive actions of non-steroidal anti-inflammatory drugs in the mouse radiant heat tail-flick test. Anesth Analg 2007;104:927-35. 13 citations

27: Gülmez SE, Gürdal H, Tulunay FC. Airway smooth muscle relaxations induced by dipyrone. Pharmacology 2006;78(4):202-8. 4 citations

28: Erdoğan F, Ergün H, Gökay NS, Gülmez SE, Bolay B, Tulunay FC. The diffusion of nimesulide (Sulidin® gel) into synovial fluid: a comparison between administration routes. Int J Clin Pharmacol Ther 2006;44(6):270-5. 2 citations

29: Gülmez SE, Tulunay FC, Beder S, Kayacan O, Karnak D. Does dipyrone have any effect on respiratory function in COPD patients? Respir Med 2006;100(5):828-34. 4 citations

30: Tulunay FC, Ergün H, Gülmez SE, Özbenli T, Özmenoğlu M, Boz C, Erdemoğlu AK, Varlıkbaş A, Göksan B, İnan L. The efficacy and safety of dipyrone (Novalgin®) tablets in the treatment of acute migraine attacks: a double-blind, cross-over, randomized, placebo-controlled multi-center study. Funct Neurol 2004; 19(3):197-202. 9 citations

31: Tulunay EO, Tulunay FC, Gülmez SE, Ergün H, Demireller A. The analgesic efficacy of dipyrone during removal of nasal packings after septal surgery. The Journal of Headache and Pain 2004; 5(4):243–6